Nonhormonal agents show promise against hot flashes.
Gottlieb
N
N
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003000:Clonidine / Q000627:therapeutic use; D000075202:Contraindications; D018849:Controlled Clinical Trials as Topic; D003511:Cyclohexanols / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008593:Menopause; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000959:Antihypertensive Agents; D003000:Clonidine; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D000069470:Venlafaxine Hydrochloride